<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01105234</url>
  </required_header>
  <id_info>
    <org_study_id>MCO 0901 FR</org_study_id>
    <secondary_id>2009-017394-38</secondary_id>
    <nct_id>NCT01105234</nct_id>
  </id_info>
  <brief_title>An Irritation Study With New Calcipotriol Ointment Formulations in Healthy Subjects</brief_title>
  <official_title>An Irritation Study With New Calcipotriol Ointment Formulations in Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LEO Pharma</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LEO Pharma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to compare the skin irritation potential of eight different
      formulations of vitamin D analogues after repeated applications on intact skin of healthy
      subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical scoring of the skin reaction.</measure>
    <time_frame>10 days</time_frame>
    <description>Clinical evaluation of the irritation on 8-level scale (from score 0: no evidence of irritation, to score 7: strong reaction speading beyond the application site)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Transepidermal waterloss measurements</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Irritation</condition>
  <arm_group>
    <arm_group_label>Calcipotriol ointment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Six different calcipotriol ointment formulations, and two currently marketed topical vitamin D analogues.</intervention_name>
    <arm_group_label>Calcipotriol ointment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects having understood and signed an informed consent form.

          -  Either sex

          -  Healthy subjects, 18 to 65 years of age

          -  Subjects with skin types I to IV according to Fitzpatrick Scale

          -  Subjects without erythema on test areas on the mid back skin (visual irritation score
             = 0) at baseline (Day 1), before randomisation.

        Exclusion Criteria:

          -  Females who are pregnant, or who wish to become pregnant during the study, or who are
             breast feeding

          -  Any topical or systemic corticosteroids or immuno-suppressors within 3 weeks prior to
             randomisation

          -  Any other medication which may interfere with the study results, in particular topical
             drugs applied on the test area within 2 weeks prior to randomisation

          -  Any other products which may interfere with the study results, in particular
             emollients, creams, gels, lotions and body powders applied on the test area within 24
             hours prior to randomisation

          -  Any systemic or cutaneous disease that may confound interpretation of the study
             results (e.g., atopic dermatitis, eczema, psoriasis)

          -  Scars, moles, sunburn, or other blemishes in the test area which may interfere with
             grading

          -  Exposure to excessive or chronic UV radiation (i.e., sunbathing, solarium,
             phototherapy) within 2 weeks prior to randomisation or is planned during the study
             period

          -  Known or suspected hypersensitivity to any component of the investigational products

          -  Participation in any other interventional clinical trial within 4 weeks prior to
             randomisation or during the study period, based on interview of the subject
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrice Facy, PhD</last_name>
    <role>Study Director</role>
    <affiliation>LEO Pharma</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>LEO Pharma site</name>
      <address>
        <city>Nice</city>
        <zip>06202</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.leo-pharma.com/Home/Research-and-Development/Clinical-trial-disclosure/Clinical-trial-summaries-and-reports.aspx</url>
    <description>Clinical Trials at LEO Pharma</description>
  </link>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 25, 2010</study_first_submitted>
  <study_first_submitted_qc>April 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2010</study_first_posted>
  <last_update_submitted>March 25, 2015</last_update_submitted>
  <last_update_submitted_qc>March 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Healthy volunteers</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Calcitriol</mesh_term>
    <mesh_term>Calcipotriene</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

